Zomedica appoints Larry Heaton as President and next CEO; Cohen to retire Nov 1

Zomedica Corp.

Larry Heaton appointed President effective Oct 1, 2021; to become CEO on Nov 1, 2021.
Robert Cohen retires as CEO but remains on Board; retirement not related to any disagreements.
Heaton granted 10M stock options at $0.58 per share, vesting in 4 equal annual installments.
Annual base salary of $400,000, eligible for target discretionary bonus of $200,000.
Heaton brings 35+ years of executive experience from medical device and biotech industries.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Larry Heaton

Chief Executive Officer

ZOMDF · Zomedica Corp.

Effective: 2021-11-01
Filed: October 4, 2021, 7:59 PM ET

On November 1, 2021, Mr. Heaton will succeed Robert Cohen as the Chief Executive Officer of the Company

Appointed

Larry Heaton

President

ZOMDF · Zomedica Corp.

Effective: 2021-10-01
Filed: October 4, 2021, 7:59 PM ET

On October 1, 2021, the Board of Directors of Zomedica Corp. (the “Company”) appointed Larry Heaton as the Company’s President, effective immediately.

Departed

Robert Cohen

Chief Executive Officer

ZOMDF · Zomedica Corp.

Effective: 2021-11-01
Successor: Larry Heaton
Filed: October 4, 2021, 7:59 PM ET

Mr. Cohen’s previously announced retirement as Chief Executive Officer will be effective.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Larry Heaton was appointed as Chief Executive Officer at Zomedica Corp..

Action: succeed
Role: Chief Executive Officer

Exact text from the filing

On November 1, 2021, Mr. Heaton will succeed Robert Cohen as the Chief Executive Officer of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Larry Heaton was appointed as President at Zomedica Corp..

Action: appointed
Role: President

Exact text from the filing

On October 1, 2021, the Board of Directors of Zomedica Corp. (the “Company”) appointed Larry Heaton as the Company’s President, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Cohen retired as Chief Executive Officer at Zomedica Corp..

Action: retired
Role: Chief Executive Officer

Exact text from the filing

Mr. Cohen’s previously announced retirement as Chief Executive Officer will be effective.

View on SEC.gov

Zomedica Corp. filing history →

Source: SEC EDGAR

accession 0001171843-21-006794

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.